Stage IIB Prostate Cancer Recruiting Phase 1 / 2 Trials for Goserelin (DB00014)

IndicationStatusPhase
DBCOND0028879 (Stage IIB Prostate Cancer)Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02346253High-Dose Brachytherapy in Treating Patients With Prostate CancerTreatment